BiographySydney Rosen, M.P.A., is a Research Professor in the Department of Global Health and the Center for Global Health & Development of the Boston University School of Public Health and the co-Division Head of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium at the University of the Witwatersrand in Johannesburg, South Africa. In collaboration with HE2RO and colleagues at BUSPH, she leads an interdisciplinary team that is carrying out a set of studies on the effectiveness, costs, and benefits of HIV/AIDS care and treatment interventions. She has also worked on other applied economics projects in the Department, including research on the economics of tuberculosis, antimicrobial resistance, malaria prevention and treatment, and air pollution. Her technical training is in public policy analysis and applied economics. She came to BUSPH in 2001 from the Health Office of the former Harvard Institute for International Development (HIID). Before joining the staff of the Health Office, she managed a set of HIID environmental policy projects in the former Soviet Union. She is also the co-founder and former executive director of WorldTeach, Inc., a nonprofit organization that places volunteer teachers in developing countries. She holds a B.A. from Harvard University and a master's degree from the Kennedy School of Government at Harvard.
- Center Faculty Member, Center for Global Health & Development , Boston University School of Public Health
- Harvard University, MPA
- Harvard University, AB
- Published on 1/21/2018
Fox MP, Pascoe SJ, Huber AN, Murphy J, Phokojoe M, Gorgens M, Rosen S, Wilson D, Pillay Y, Fraser-Hurt N. Assessing the impact of the National Department of Health's National Adherence Guidelines for Chronic Diseases in South Africa using routinely collected data: a cluster-randomised evaluation. BMJ Open. 2018 01 21; 8(1):e019680. PMID: 29358446.
- Published on 1/10/2018
Bor J, Chiu C, Ahmed S, Katz I, Fox MP, Rosen S, Yapa M, Tanser F, Pillay D, Bärnighausen T. Failure to initiate HIV treatment in patients with high CD4 counts: evidence from demographic surveillance in rural South Africa. Trop Med Int Health. 2018 Feb; 23(2):206-220. PMID: 29160949.
- Published on 11/28/2017
Bor J, Fox MP, Rosen S, Venkataramani A, Tanser F, Pillay D, Bärnighausen T. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa. PLoS Med. 2017 Nov; 14(11):e1002463. PMID: 29182641.
- Published on 10/30/2017
Meyer-Rath G, Johnson LF, Pillay Y, Blecher M, Brennan AT, Long L, Moultrie H, Sanne I, Fox MP, Rosen S. Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS One. 2017; 12(10):e0186557. PMID: 29084275.
- Published on 10/26/2017
Meyer-Rath G, van Rensburg C, Larson B, Jamieson L, Rosen S. Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case. PLoS One. 2017; 12(10):e0186496. PMID: 29073167.
- Published on 10/13/2017
Hoffman R, Bardon A, Rosen S, Fox M, Kalua T, Xulu T, Taylor A, Sanne I. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial. Trials. 2017 Oct 13; 18(1):476. PMID: 29029644.
- Published on 10/2/2017
Stokes A, Berry KM, Mchiza Z, Parker WA, Labadarios D, Chola L, Hongoro C, Zuma K, Brennan AT, Rockers PC, Rosen S. Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: Evidence from the SANHANES-1, 2011-2012. PLoS One. 2017; 12(10):e0184264. PMID: 28968435.
- Published on 8/16/2017
Berry KM, Parker WA, Mchiza ZJ, Sewpaul R, Labadarios D, Rosen S, Stokes A. Quantifying unmet need for hypertension care in South Africa through a care cascade: evidence from the SANHANES, 2011-2012. BMJ Glob Health. 2017; 2(3):e000348. PMID: 29082013.
- Published on 7/26/2017
Evans D, Schnippel K, Govathson C, Sineke T, Black A, Long L, Berhanu R, Rosen S. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2017; 12(7):e0181238. PMID: 28746344.
- Published on 7/17/2017
Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, Sanne I, Fox MP, Rosen S. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017 Jul 17; 31(11):1611-1619. PMID: 28463879.
View 73 more publications:View full profile at BUMC
News & In the Media
- Published on November 28, 2017
- Published on November 13, 2017
- Published on October 2, 2017
- Published on September 12, 2017
- Published on September 6, 2017
- Published on July 5, 2017
- Published on January 3, 2017
- Published on May 20, 2016
- Published on May 19, 2016
- Published on May 16, 2016